Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|9|E181-E182

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.9, 2015-09, pp. : E181-E182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 2018-02 ,pp. : 154-162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute promyelocytic leukaemia with t(11;17)(q23;q12‐21) and a good initial response to prolonged ATRA and combination chemotherapy

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 1998-02 ,pp. : 328-330

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coagulopathy of Acute Promyelocytic Leukemia

By  

Acta Haematologica, Vol. 106, Iss. 1-2, 2001-09 ,pp. : 43-51

Karger

Access to resources Recommend Favorite

High-Risk Acute Promyelocytic Leukemia with Early Differentiation Syndrome: A Therapeutic Dilemma

By  

Acta Haematologica, Vol. 127, Iss. 1, 2011-11 ,pp. : 60-62

Karger

Access to resources Recommend Favorite

Acute Promyelocytic Leukemia with Flt3-TKD and WT1 Mutations Relapsing in a Testicle and Followed by Systemic Relapse

By  

Acta Haematologica, Vol. 130, Iss. 4, 2013-06 ,pp. : 223-229

Karger

Access to resources Recommend Favorite